acetylcysteine has been researched along with P carinii Pneumonia in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Legnani, D | 1 |
| Meissner, N; Taylor, D; Voyich, J; Wilkison, M | 1 |
| Akerlund, B; Bielenstein, M; Bratt, G; Lidman, C; Tynell, E | 1 |
| Djurdjev, O; Khorasheh, S; Singer, J; Walmsley, SL | 1 |
| Eveland, WC; Lim, SK; Porter, RJ | 1 |
1 review(s) available for acetylcysteine and P carinii Pneumonia
| Article | Year |
|---|---|
[Acute bacterial exacerbation of chronic obstructive pulmonary disease and biofilm].
Topics: Acetylcysteine; Anti-Infective Agents; Antioxidants; Biofilms; Bronchi; Bronchitis; Cystic Fibrosis; Humans; Lung; Pneumocystis carinii; Pneumonia, Bacterial; Pneumonia, Pneumocystis; Pneumonia, Viral; Practice Guidelines as Topic; Pulmonary Disease, Chronic Obstructive | 2009 |
2 trial(s) available for acetylcysteine and P carinii Pneumonia
| Article | Year |
|---|---|
N-acetylcysteine treatment and the risk of toxic reactions to trimethoprim-sulphamethoxazole in primary Pneumocystis carinii prophylaxis in HIV-infected patients.
Topics: Acetylcysteine; Adult; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Cysteine; Exanthema; Female; Fever; Glutathione; Humans; Male; Pneumocystis; Pneumonia, Pneumocystis; Trimethoprim, Sulfamethoxazole Drug Combination | 1997 |
A randomized trial of N-acetylcysteine for prevention of trimethoprim-sulfamethoxazole hypersensitivity reactions in Pneumocystis carinii pneumonia prophylaxis (CTN 057). Canadian HIV Trials Network 057 Study Group.
Topics: Acetylcysteine; Adult; Anti-Infective Agents; Drug Hypersensitivity; Female; Free Radical Scavengers; HIV Infections; Humans; Incidence; Male; Middle Aged; Outcome Assessment, Health Care; Pneumonia, Pneumocystis; Primary Prevention; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1998 |
3 other study(ies) available for acetylcysteine and P carinii Pneumonia
| Article | Year |
|---|---|
Prevention of bone marrow cell apoptosis and regulation of hematopoiesis by type I IFNs during systemic responses to pneumocystis lung infection.
Topics: Acetylcysteine; Animals; Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Bone Marrow Cells; Caspase 8; Caspase 9; Genes, bcl-2; Genes, RAG-1; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoiesis; Inhibitor of Apoptosis Proteins; Interferon Type I; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, SCID; Molecular Sequence Data; Myeloid Cell Leukemia Sequence 1 Protein; Myeloid Progenitor Cells; Neutrophils; Oxidative Stress; Pneumocystis; Pneumonia, Pneumocystis; Polymerase Chain Reaction; Proto-Oncogene Proteins c-bcl-2; Radiation Chimera; Receptor, Interferon alpha-beta; RNA, Messenger; Signal Transduction; Tumor Necrosis Factor-alpha; Ubiquitin-Protein Ligases | 2011 |
Study finds NAC fails to prevent Bactrim/Septra hypersensitivity.
Topics: Acetylcysteine; AIDS-Related Opportunistic Infections; Anti-Infective Agents; Drug Hypersensitivity; Free Radical Scavengers; Humans; Pneumonia, Pneumocystis; Primary Prevention; Toxoplasmosis; Trimethoprim, Sulfamethoxazole Drug Combination | 1999 |
Direct fluorescent-antibody method for the diagnosis of Pneumocystis carinii pneumonitis from sputa or tracheal aspirates from humans.
Topics: Acetylcysteine; Adolescent; Adult; Antibodies; Antigens; Biopsy; Child; Child, Preschool; Diagnosis, Differential; Evaluation Studies as Topic; Fluorescent Antibody Technique; Humans; Lung; Methenamine; Methods; Middle Aged; Pneumocystis; Pneumonia, Pneumocystis; Silver; Sputum; Staining and Labeling; Trachea | 1974 |